The Drug Development Process from Concept to Market

  • Check with publisher
  • Published date: May 22, 2021
    • san Jose, california, United States

This course is designed to cater for employees of pharmaceutical companies who would like an understanding of the drug development and regulatory approval process. The course starts by considering the global pharmaceutical market, important therapeutic areas and the roles of different pharmaceutical professionals in the development process, as well as a definition of drugs and medical devices. The drug development process, from discovery to post-marketing surveillance, is then explained. Topics include the identification of drug targets, synthesis of chemical drugs and the development of biologics, pharmacokinetics and toxicity screening, pre-clinical development, clinical studies, regulatory submissions, managing post-approval change, pharmacovigilance and an overview of regulations governing drug manufacture and distribution.

Result 0 votes
Ashutos Swain
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Data Integrity: FDA/EMA Requirements and Implementation

    Data Integrity: FDA/EMA Requirements and Implementation

    Pharmacology - Drug Development san Jose (california) May 22, 2021 Check with publisher

    The integrity of data generated in support of marketing authorizations and in GMP, GCP and GLP regulated activities is foundational to sound decision making and regulatory compliance. Data integrity lapses are among the most serious concerns that pha...

  • Process Validation Guidance Requirements (FDA and EU Annex 15

    Process Validation Guidance Requirements (FDA and EU Annex 15

    Pharmacology - Drug Development san Jose (california) May 15, 2021 Check with publisher

    The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manu...

  • Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)

    Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)

    Pharmacology - Drug Development san Jose (california) May 15, 2021 Check with publisher

    Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a...